Hideki Tokaibayashi
Directeur/Membre du Conseil chez TELLA, INC.
Postes actifs de Hideki Tokaibayashi
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| TELLA, INC. | Directeur/Membre du Conseil | 01/03/2021 | - |
| GranCharite Co. Ltd. | Directeur/Membre du Conseil | 01/11/2017 | - |
Historique de carrière de Hideki Tokaibayashi
Anciens postes connus de Hideki Tokaibayashi
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| REMIXPOINT, INC. | Directeur/Membre du Conseil | 01/06/2020 | 28/06/2022 |
| Independent Dir/Board Member | 01/06/2020 | 28/06/2022 |
Statistiques
Internationale
| Japon | 4 |
Opérationnelle
| Director/Board Member | 3 |
| Independent Dir/Board Member | 1 |
Sectorielle
| Technology Services | 2 |
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| REMIXPOINT, INC. | Technology Services |
| Entreprise privées | 2 |
|---|---|
tella, Inc.
 tella, Inc. BiotechnologyHealth Technology tella, Inc. engages in research and development of dendritic cell (DC) vaccine therapy. It operates through the following segments: Cell Medicine, Medical Support, and Pharmaceuticals. The Cell Medicine segment provides cancer treatment technology and know-hows centered on dendritic cell vaccine therapy. The Medical Support segment manages contact research organization (CRO) business and offers genetic testing services. The Pharmaceuticals segment deals with the development of dendritic cell vaccine as a cancer treatment. The company was founded by Yuichiro Yazaki on June 24, 2004 and is headquartered in Tokyo, Japan. | Health Technology |
| GranCharite Co. Ltd. |
- Bourse
- Insiders
- Hideki Tokaibayashi
- Expérience